Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 60 2015 048 860.1 |
96 | EP file number | EAKZ | 19 15 1238.3 |
97 | EP publication number | EPN | 3514172 |
54 | Designation/title | TI | CLAUDIN-6-SPEZIFISCHE IMMUNREZPTOREN UND T-ZELL-EPITOPE |
51 | IPC main class | ICM (ICMV) | C07K 14/725 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | C07K 14/47 (2006.01), A61P 35/00 (2006.01), A61K 35/26 (2015.01) |
22 | DE application date | DAT | Mar 30, 2015 |
96 | EP application date | EAT | Mar 30, 2015 |
43 | Date of first publication | OT | Jul 24, 2019 |
| Date of publication of grant | PET | Mar 11, 2020 |
71/73 | Applicant/owner | INH | Astellas Pharma Inc., Tokyo, JP; BioNTech Cell & Gene Therapies GmbH, 55131 Mainz, DE; TRON - Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz gemeinnützige GmbH, 55131 Mainz, DE |
72 | Inventor | IN | Sahin, Ugur, 55116 Mainz, DE; Türeci, Özlem, 55116 Mainz, DE; Oehm, Petra, 55129 Mainz, DE; OMOKOKO, Tana, 55116 Mainz, DE; HOFF, Holger, 10115 Berlin, DE; VOSS, Ralf-Holger, 55218 Ingelheim, DE; BREITKREUZ, Andrea, 67551 Worms, DE; HOBOHM, Kathleen, 65779 Kelkheim i. Ts., DE; MROZ, Karolina Anna, 55131 Mainz, DE |
74 | Representative | VTR | Zwicker Schnappauf & Partner Patentanwälte PartG mbB, 80686 München, DE |
| Address for service | | Zwicker Schnappauf & Partner Patentanwälte PartG mbB, 80686 München, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| WO PCT/EP2014/072864 Oct 24, 2014
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| WO PCT/EP2014/000868 Apr 1, 2014
|
| Due date | FT FG | Mar 31, 2026 Annual fee for the 12th year
Patent fees |
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000003514172A1 Searchable text:
EP000003514172A1 Original document:
EP000003514172B1 Searchable text:
EP000003514172B1 |
43 | Date of first publication | EVT | Jul 24, 2019 |
| Date of the first transfer into DPMAregister | EREGT | Jul 24, 2019 |
| Date of the (most recent) update in DPMAregister | REGT | Apr 3, 2025 (Show all update days)(Hide all update days)- Apr 3, 2025
- Nov 13, 2024
- St.36: changed (technical change)
- Mar 27, 2024; Aug 31, 2023; Jul 25, 2023; Mar 30, 2023; Mar 26, 2022; Mar 30, 2021; Mar 5, 2021; Jan 28, 2021; Mar 19, 2020; Mar 13, 2020; Mar 7, 2020; Mar 3, 2020; Feb 21, 2020; Feb 20, 2020; Aug 23, 2019; Jul 25, 2019
- Historical data not available for this/these date(s)
- Jul 24, 2019
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 7)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Jul 24, 2023 |
| Issue number | HN | 35 |
| Year | PJ | 2023 |
| Publication date | VT | Aug 31, 2023 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 3 |
71/73 | Applicant/owner | INH | Astellas Pharma Inc., Tokyo, JP; BioNTech Cell & Gene Therapies GmbH, 55131 Mainz, DE; TRON - Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz gemeinnützige GmbH, 55131 Mainz, DE |
71/73 | Previous applicant/owner | INHF | BioNTech Cell & Gene Therapies GmbH, 55131 Mainz, DE, Ganymed Pharmaceuticals GmbH, 55131 Mainz, DE, TRON - Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz gemeinnützige GmbH, 55131 Mainz, DE |
| Date of update of the procedure | REGT | Aug 31, 2023 |